Neurocore LLC is a US-based preclinical drug development contract research partner committed to advancing the development of regulated products in stem cell therapies, gene therapies, and implantable devices for neurodegenerative, neuro-oncologic and metabolic indications.
Nonclinical support for cell and gene-based therapeutic development
Scientific expertise and development of animal models
Integration with client resources at multiple levels
Emphasis on regulatory requirements
Strategic planning to IND submission
Active participation in pre-pre-IND and pre-IND meetings
Neurocore LLC has more direct experience in developing stem cell therapies for the CNS than any existing USA-based CRO. Our expertise extends to all phases of cell-based and gene based product development and our experts can give your product the advantage of 40 combined years of cell therapy experience. Our multi-disciplinary team of experts, located in San Diego, provides an integrated service solution, to include preclinical, regulatory, toxicology, clinical evaluation and translational capabilities.
Neurocore LLC provides expertise in the evaluation and generation of in vivo neurodegeneration, neuro-oncology and metabolic disease models integrated with expert consultation from the scientific, regulatory compliance and medical/clinical areas to assist in planning and implementing your drug development program from early research to clinical trials.